StocksEditas Medicine IncEDIT

EDIT

Editas Medicine Inc

18.71 0.66 (3.65%)
Forsinkede priser fra NASDAQ, i USD Markedet stengt
Handle
S
18.71
K
18.78
Festet innlegg
Genome Engineering
Vertex, Verve team up to develop a gene editing drug for liver disease 🔹 $VRTX (Vertex Pharmaceuticals Incorporated) is broadening its reach in gene editing, announcing Wednesday a deal with $VERV (Verve Therapeutics Inc) to develop a one-time treatment for an undisclosed liver disease. Vertex will... Vis flere Oversett